March 3, 2020 03:30 PM

CADILA HEALTHCARE share price has zoomed 5% and is presently trading at Rs 262.

Meanwhile, the BSE HEALTHCARE Index is at 13,968 (up 4.1%).

Among the top Gainers in the BSE HEALTHCARE Index today are CADILA HEALTHCARE (up 5.0%) and DR. REDDYS LAB (up 5.4%).

ALEMBIC PHARMA (down 0.2%) and PROCTER & GAMBLE HEALTH (down 0.8%) are among the top losers today.

Over the last one year, CADILA HEALTHCARE has moved down from Rs 331 to Rs 262, registering a loss of Rs 69 (down 20.8%).

On the other hand, the BSE HEALTHCARE has moved down from 14,019 to 13,968, loss of 51 points (down 0.4%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 112.1%), IPCA LABS (up 72.4%) and DR. LAL PATHLABS LTD (up 64.7%).

What About the Benchmark Indices?

The BSE Sensex is at 38,754 (up 1.4%).

The top gainers among the BSE Sensex stocks today are SUN PHARMA (up 7.3%), TATA STEEL (up 7.2%) and NTPC (up 5.6%). Other gainers include POWER GRID (up 5.3%) and ONGC (up 5.1%). The most traded stocks in the BSE Sensex are SBI and ONGC.

In the meantime, NSE Nifty is at 11,342 (up 1.8%). VEDANTA LTD (up 8.3%) and SUN PHARMA (up 7.2%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 36,443 to 38,754, registering a gain of 2,311 points (up 6.1%).

CADILA HEALTHCARE Financial Update...

CADILA HEALTHCARE net profit down at Rs 4 billion for the quarter ended December 2019, compared to a loss of Rs 5 billion a year ago. Net Sales rose 1.7% to Rs 36.4 billion during the period as against Rs 35.8 billion in October-December 2018.

For the year ended March 2019, CADILA HEALTHCARE reported 4.8% increase in net profit to Rs 18.5 billion compared to net profit of Rs 17.7 billion during FY18.

Revenue of the company grew 10.1% to Rs 132 billion during FY19.

The current Price to earnings ratio of CADILA HEALTHCARE, based on rolling 12 month earnings, stands at 21.6x.